News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ENVB market cap is 2.11M. The company's latest EPS is USD -7.5212 and P/E is -0.12.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.66M | -12.26M | -4.86M | -5.76M | -3.45M |
| Net Income | -2.6M | -8.8M | -4.8M | -6.4M | -2.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 39.92M | 0 | 0 | 0 | 0 |
| Operating Income | -6.32M | -5.62M | -25.95M | -27.42M | -16.45M |
| Net Income | -6.03M | -6.87M | -48.98M | -18.8M | -17.46M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.86M | 19.55M | 15.85M | 9.8M | 6.62M |
| Total Liabilities | 7.25M | 4M | 4.44M | 4.93M | 4.18M |
| Total Equity | 22.84M | 14.67M | 10.41M | 4.88M | 2.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 25.01M | 4.1M | 26.72M | 19.55M | 4.3M |
| Total Liabilities | 14.38M | 681k | 4.41M | 4M | 2.34M |
| Total Equity | 10.62M | 3.42M | 22.31M | 14.67M | 1.96M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.69M | -17.15M | -5.14M | -9.6M | -12.34M |
| Investing | -578k | -584k | -5k | 11k | 12k |
| Financing | 18.18M | 18.18M | N/A | -1.05M | -1.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.45M | -3.89M | -11.46M | -17.15M | -14.1M |
| Investing | -284k | -44k | 2.19M | -584k | 12k |
| Financing | 1.8M | 5.53M | 24.9M | 18.18M | -1.34M |
| Market Cap | 2.11M |
| Price to Earnings Ratio | -0.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.91 |
| Price to Book Ratio | 1.07 |
| Dividend Yield | - |
| Shares Outstanding | 2.32M |
| Average Volume (1 week) | 117.04k |
| Average Volume (1 Month) | 248.41k |
| 52 Week Change | -44.17% |
| 52 Week High | 6.98 |
| 52 Week Low | 0.649 |
| Spread (Intraday) | 0.01 (1.09%) |
| Company Name | Enveric Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.enveric.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
